These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17286319)

  • 1. Statins and fracture risk. A systematic review.
    Toh S; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):627-40. PubMed ID: 17286319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-Analysis.
    Shi R; Mei Z; Zhang Z; Zhu Z
    J Am Med Dir Assoc; 2019 Dec; 20(12):1566-1578.e3. PubMed ID: 31395495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
    Hatzigeorgiou C; Jackson JL
    Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
    Coons JC
    Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we abandon statins in the prevention of bone fractures?
    Esposito K; Capuano A; Sportiello L; Giustina A; Giugliano D
    Endocrine; 2013 Oct; 44(2):326-33. PubMed ID: 23526261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials.
    Yue J; Zhang X; Dong B; Yang M
    Menopause; 2010; 17(5):1071-9. PubMed ID: 20473231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
    Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
    Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.
    Wang PS; Solomon DH; Mogun H; Avorn J
    JAMA; 2000 Jun; 283(24):3211-6. PubMed ID: 10866868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
    Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
    J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal effects of statins.
    Yaturu S
    Endocr Pract; 2003; 9(4):315-20. PubMed ID: 14561578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of HMG-CoA reductase inhibitors for osteoporosis.
    Cushenberry LM; de Bittner MR
    Ann Pharmacother; 2002 Apr; 36(4):671-8. PubMed ID: 11918519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
    Bauer DC
    Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
    Pradelli D; Soranna D; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
    Cancer Med; 2015 May; 4(5):770-80. PubMed ID: 25809667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.
    Nichols R; Hopman WM; Morton AR; Harman GJ; Holden RM
    Hemodial Int; 2008 Apr; 12(2):275-9. PubMed ID: 18394063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hip fracture risk in statin users--a population-based Danish case-control study.
    Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
    Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and fracture risk: study of a US veterans population.
    Scranton RE; Young M; Lawler E; Solomon D; Gagnon D; Gaziano JM
    Arch Intern Med; 2005 Sep; 165(17):2007-12. PubMed ID: 16186471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and fracture risk: can we quantify the healthy-user effect?
    McCandless LC
    Epidemiology; 2013 Sep; 24(5):743-52. PubMed ID: 23883870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.